European Commission President Ursula von der Leyen survived a no-confidence vote sparked by far-right lawmakers. They cited a ...

Researchers are ushering in a new era of vaccine design that promises to be faster, more precise, and capable of tackling humanity’s most stubborn diseases.

Fianna Fáil’s four MEPs will not be supporting a motion of no-confidence in European Commission president Ursula von der Leyen this week, which has been tabled by far-right parties.

Fianna Fáil MEPs have come under pressure for suggesting they might support a motion of no-confidence in European Commission president Ursula von der Leyen. The no-confidence vote was tabled by a ...

Supporters of a motion of censure against Commission President Ursula von der Leyen hope it will put enough political pressure on her leadership to force a resignation – mirroring the 1999 downfall of ...

The motion, brought forward by far-right lawmakers, was overwhelmingly defeated. A total of 360 MEPs voted against it, while ...

EU chief Ursula von der Leyen faces a confidence vote Thursday that has little chance of succeeding but has exposed frictions ...

The European Commission president was forced to walk away from $165 billion in economic competitiveness reforms and defense spending pivots, exposing Europe's struggle to match U.S. and Chinese ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...

Pfizer’s announcement about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day, but Pfizer CEO Albert Bourla has said the timing had nothing to do with politics.